14 research outputs found
Π₯ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΡ ΠΎΠΏΡΡΠ΅Π½ΠΈΡ ΠΏΠ΅ΡΠ΅Π΄Π½Π΅ΠΉ ΡΡΠ΅Π½ΠΊΠΈ Π²Π»Π°Π³Π°Π»ΠΈΡΠ° ΠΈ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ ΠΏΡΠΈ ΠΏΠΎΠΌΠΎΡΠΈ ΡΠ΅ΡΡΠ°ΡΡΡ ΡΠΈΡΠ°Π½ΠΎΠ²ΡΡ ΠΈΠΌΠΏΠ»Π°Π½ΡΠ°ΡΠΎΠ²
Background: Regardless of a variety of surgical techniques and hi-tech materials for pelvic prolapse treatment, there is no decrease in the disease recurrences.
Aims: Evaluation of the efficacy of the developed method of surgical correction of IIIV degree colpoptosis anterior combined with IIIII degree C-prolapse with the use of titanium mesh implants in reproductive, pre- and postmenopausal female patients.
Methods: Female patients (group I, n = 25) with colpoptosis anterior and cervical prolapse were examined and operated on according to the developed know-how technique with the use of titanium mesh implants. Evaluation of the efficacy of surgical correction of the disease was performed using questioning, pelvic exam with Valsalva manoeuvre, transvaginal and transperineal ultrasound, pelvis MRI. The findings were compared with the result of surgical treatment of 46 (group II) and 32 (group III) female patients operated on without the use of titanium implants. After surgical treatment according to the three-stage surgical program that provides for multifocal fixation of anatomical formations with the use of titanium implants, the case follow-up was performed in 321 months.
Results: Questioning the patients in group I demonstrated their satisfaction with the surgical treatment results that positively affected the quality of life, mood, and contributed to an increase in sexual activity and community commitment. Check-up showed that the surgical correction of prolapse was completely preserved in the patients of group I during 1821 months. Pelvic exam at rest and with Valsalva manoeuvre, transvaginal and transperineal ultrasound, pelvis MRI did not reveal any significant extrusion of the pelvic organs or titanium implants. No mesh-associated complications were observed during the follow-up. Recurrence of genital prolapse was diagnosed in 12 (26%) patients of group II, mesh-associated complications were detected in 6 (18.8%) women of group III.
Conclusions: The preserving three-stage surgical program, developed by us, contributed to optimize the results of surgical treatment, decrease the rate of the disease recurrence, and reduce the risk of the development of mesh-associated complications.ΠΠ±ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠ΅. ΠΠ΅ΡΠΌΠΎΡΡΡ Π½Π° Π½Π°Π»ΠΈΡΠΈΠ΅ ΡΠ°Π·Π½ΠΎΠΎΠ±ΡΠ°Π·Π½ΡΡ
Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊ ΠΈ Π²ΡΡΠΎΠΊΠΎΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΡΠ½ΡΡ
ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»ΠΎΠ² Π΄Π»Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΡΠΎΠ»Π°ΠΏΡΠ° ΡΠ°Π·ΠΎΠ²ΡΡ
ΠΎΡΠ³Π°Π½ΠΎΠ², ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ ΡΠ΅ΡΠΈΠ΄ΠΈΠ²ΠΎΠ² Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π½Π΅ ΡΠ½ΠΈΠΆΠ°Π΅ΡΡΡ.
Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΎΡΠ΅Π½ΠΊΠ° ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½ΠΎΠ³ΠΎ ΡΠΏΠΎΡΠΎΠ±Π° Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠΈ ΠΎΠΏΡΡΠ΅Π½ΠΈΡ ΠΏΠ΅ΡΠ΅Π΄Π½Π΅ΠΉ ΡΡΠ΅Π½ΠΊΠΈ Π²Π»Π°Π³Π°Π»ΠΈΡΠ° IIIV ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Π² ΡΠΎΡΠ΅ΡΠ°Π½ΠΈΠΈ Ρ Π‘-ΠΏΡΠΎΠ»Π°ΠΏΡΠΎΠΌ IIIII ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΏΡΠΈ ΠΏΠΎΠΌΠΎΡΠΈ ΡΠΈΡΠ°Π½ΠΎΠ²ΡΡ
ΡΠ΅ΡΡΠ°ΡΡΡ
ΠΈΠΌΠΏΠ»Π°Π½ΡΠ°ΡΠΎΠ² Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ, ΠΏΡΠ΅- ΠΈ ΠΏΠΎΡΡΠΌΠ΅Π½ΠΎΠΏΠ°ΡΠ·Π°Π»ΡΠ½ΠΎΠ³ΠΎ Π²ΠΎΠ·ΡΠ°ΡΡΠ°.
ΠΠ΅ΡΠΎΠ΄Ρ. ΠΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ ΠΈ ΠΏΡΠΎΠΎΠΏΠ΅ΡΠΈΡΠΎΠ²Π°Π½Ρ ΠΏΠΎ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½ΠΎΠΉ ΠΎΡΠΈΠ³ΠΈΠ½Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠ΅ Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΡΠ΅ΡΡΠ°ΡΡΡ
ΡΠΈΡΠ°Π½ΠΎΠ²ΡΡ
ΠΈΠΌΠΏΠ»Π°Π½ΡΠ°ΡΠΎΠ² ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ (I Π³ΡΡΠΏΠΏΠ°, n = 25) Ρ ΠΎΠΏΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΏΠ΅ΡΠ΅Π΄Π½Π΅ΠΉ ΡΡΠ΅Π½ΠΊΠΈ Π²Π»Π°Π³Π°Π»ΠΈΡΠ° ΠΈ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ. ΠΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΏΡΡΠ΅ΠΌ Π°Π½ΠΊΠ΅ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ Ρ ΠΏΠΎΠΌΠΎΡΡΡ Π²Π°Π»ΠΈΠ΄ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΎΠΏΡΠΎΡΠ½ΠΈΠΊΠΎΠ², Π³ΠΈΠ½Π΅ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Ρ ΠΏΡΠΎΠ±ΠΎΠΉ ΠΠ°Π»ΡΡΠ°Π»ΡΠ²Ρ, ΡΡΠ°Π½ΡΠ²Π°Π³ΠΈΠ½Π°Π»ΡΠ½ΠΎΠΉ ΠΈ ΡΡΠ°Π½ΡΠΏΠ΅ΡΠΈΠ½Π΅Π°Π»ΡΠ½ΠΎΠΉ ΡΡ
ΠΎΠ³ΡΠ°ΡΠΈΠΈ, ΠΌΠ°Π³Π½ΠΈΡΠ½ΠΎ-ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ½ΠΎΠΉ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΠΈ (ΠΠ Π’) ΠΌΠ°Π»ΠΎΠ³ΠΎ ΡΠ°Π·Π°. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΡΡΠ°Π²Π½ΠΈΠ²Π°Π»ΠΈ Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌΠΈ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ 46 (II Π³ΡΡΠΏΠΏΠ°) ΠΈ 32 (III Π³ΡΡΠΏΠΏΠ°) ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ, ΠΏΡΠΎΠΎΠΏΠ΅ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π±Π΅Π· ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΠΈΡΠ°Π½ΠΎΠ²ΡΡ
ΠΈΠΌΠΏΠ»Π°Π½ΡΠ°ΡΠΎΠ². ΠΠ±ΡΠ΅ΠΌ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π° Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ II Π³ΡΡΠΏΠΏΡ β ΠΏΠ΅ΡΠ΅Π΄Π½ΡΡ ΠΊΠΎΠ»ΡΠΏΠΎΡΠ°ΡΠΈΡ, III Π³ΡΡΠΏΠΏΡ β ΠΏΠ΅ΡΠ΅Π΄Π½ΠΈΠΉ Prolift ΠΏΠΎΠ»ΠΈΠΏΡΠΎΠΏΠΈΠ»Π΅Π½ΠΎΠ²ΡΠΌΠΈ ΠΈΠΌΠΏΠ»Π°Π½ΡΠ°ΡΠ°ΠΌΠΈ. ΠΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΠΎ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½ΠΎΠΉ ΡΡΠ΅Ρ
ΡΡΠ°ΠΏΠ½ΠΎΠΉ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΠ΅, ΠΏΡΠ΅Π΄ΡΡΠΌΠ°ΡΡΠΈΠ²Π°ΡΡΠ΅ΠΉ ΠΌΡΠ»ΡΡΠΈΡΠΎΠΊΠ°Π»ΡΠ½ΡΡ ΡΠΈΠΊΡΠ°ΡΠΈΡ Π°Π½Π°ΡΠΎΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΡΡΡΠΊΡΡΡ ΠΏΡΠΈ ΠΏΠΎΠΌΠΎΡΠΈ ΡΠΈΡΠ°Π½ΠΎΠ²ΡΡ
ΠΈΠΌΠΏΠ»Π°Π½ΡΠ°ΡΠΎΠ², ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠ΅ ΡΠ΅ΡΠ΅Π· 3, 6, 9, 12, 15, 18 ΠΈ 21 ΠΌΠ΅Ρ.
Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠ½ΠΊΠ΅ΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ I Π³ΡΡΠΏΠΏΡ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΎ ΡΠ΄ΠΎΠ²Π»Π΅ΡΠ²ΠΎΡΠ΅Π½Π½ΠΎΡΡΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌΠΈ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ, ΡΡΠΎ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎ ΠΎΡΡΠ°Π·ΠΈΠ»ΠΎΡΡ Π½Π° ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΆΠΈΠ·Π½ΠΈ ΠΈ Π½Π°ΡΡΡΠΎΠ΅Π½ΠΈΠΈ, ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΠΎΠ²Π°Π»ΠΎ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΡΠ΅ΠΊΡΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΈ ΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ. ΠΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΎ ΡΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΠ΅ ΠΏΠΎΠ»Π½ΠΎΠΉ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠΈ ΠΏΡΠΎΠ»Π°ΠΏΡΠ° Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ I Π³ΡΡΠΏΠΏΡ Π½Π° ΠΏΡΠΎΡΡΠΆΠ΅Π½ΠΈΠΈ 1821 ΠΌΠ΅Ρ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ. ΠΡΠΈ Π³ΠΈΠ½Π΅ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ Π² ΠΏΠΎΠΊΠΎΠ΅ ΠΈ ΠΏΡΠΈ ΠΏΡΠΎΠ±Π΅ ΠΠ°Π»ΡΡΠ°Π»ΡΠ²Ρ, ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ ΡΡΠ°Π½ΡΠ²Π°Π³ΠΈΠ½Π°Π»ΡΠ½ΠΎΠΉ ΠΈ ΡΡΠ°Π½ΡΠΏΠ΅ΡΠΈΠ½Π΅Π°Π»ΡΠ½ΠΎΠΉ ΡΡ
ΠΎΠ³ΡΠ°ΡΠΈΠΈ, ΠΠ Π’, Π·Π½Π°ΡΠΈΠΌΠΎΠ³ΠΎ ΡΠΌΠ΅ΡΠ΅Π½ΠΈΡ ΡΠ°Π·ΠΎΠ²ΡΡ
ΠΎΡΠ³Π°Π½ΠΎΠ² ΠΈ ΡΠΈΡΠ°Π½ΠΎΠ²ΡΡ
ΠΈΠΌΠΏΠ»Π°Π½ΡΠ°ΡΠΎΠ² Π½Π΅ Π²ΡΡΠ²Π»Π΅Π½ΠΎ. Mesh-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡ Π·Π° Π²ΡΠ΅ΠΌΡ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ ΠΎΡΡΡΡΡΡΠ²ΠΎΠ²Π°Π»ΠΈ. Π£ 12 (26%) ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ II Π³ΡΡΠΏΠΏΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠΎΠ²Π°Π½ ΡΠ΅ΡΠΈΠ΄ΠΈΠ² Π³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΠ»Π°ΠΏΡΠ°, Ρ 6 (18,8%) ΠΆΠ΅Π½ΡΠΈΠ½ III Π³ΡΡΠΏΠΏΡ Π²ΡΡΠ²Π»Π΅Π½Ρ mesh-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡ.
ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½Π°Ρ Π½Π°ΠΌΠΈ ΠΎΡΠ³Π°Π½ΠΎΡΠ±Π΅ΡΠ΅Π³Π°ΡΡΠ°Ρ ΡΡΠ΅Ρ
ΡΡΠ°ΠΏΠ½Π°Ρ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΠ° ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΠΎΠ²Π°Π»Π° ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ, ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΡ ΡΠ°ΡΡΠΎΡΡ ΡΠ΅ΡΠΈΠ΄ΠΈΠ²ΠΎΠ² Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ mesh-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ
Crystal structure of copper(II) pivaloyltrifluoracetonate adducts with o-phenanthroline and 2,2'-dipyridyl
The crystal structure of Cu(pta)(2) . Phen has been determined. The phenanthroline ligand occupies a position in the equatorial plane of the tetragonally distorted octahedron with equal Cu-N distances and equivalent beta-diketonate-anions. Cu(pta)(2) . 2,2'-Dipy is isostructural to Cu(pta)(2) . Phen. The volatility of adducts decreases in the sequence Cu(thd)(2) . Phen, Cu(pta(2)). Phen and Cu(hfa)(2) . Phen changing inversely to that of the beta-diketonates. The variation of packing mode caused by the difference of the molecular structure is considered to be responsible for the effect. The changes of the electronic spectra of copper(II) beta-diketonates caused by adduct formation are discussed. (C) 1997 Elsevier Science Ltd